UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
NeuBase Therapeutics, Inc.
|
Common Stock, par value $0.0001 per share
|
64132K102
|
Decembner 31, 2020
|
(Date of Event which Requires Filing of this Statement)
|
1
|
Names of Reporting Persons.
Greenlight Capital, Inc.
|
|||
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|||
(a) [ ]
|
||||
(b) [ ]
|
||||
3
|
SEC Use Only
|
|||
4
|
Citizenship or Place of Organization.
Delaware
|
|||
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
0 shares
|
|||
6 Shared Voting Power
945,196 shares
|
||||
7 Sole Dispositive Power
0 shares
|
||||
8 Shared Dispositive Power
945,196 sshares
|
||||
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
945,196 sshares
|
|||
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ]
|
|||
11
|
Percent of Class Represented by Amount in Row (9)
4.1%
|
|||
12
|
Type of Reporting Person (See Instructions)
IA
|
1
|
Names of Reporting Persons.
DME Capital Management, LP
|
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
(a) [ ]
|
||
(b) [ ]
|
||
3
|
SEC Use Only
|
|
4
|
Citizenship or Place of Organization.
Delaware
|
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
0 shares
|
|
6 Shared Voting Power
889,931 shares
|
||
7 Sole Dispositive Power
0 shares
|
||
8 Shared Dispositive Power
889,931 shares
|
||
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
889,931 shares
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ]
|
|
11
|
Percent of Class Represented by Amount in Row (9)
3.8%
|
|
12
|
Type of Reporting Person (See Instructions)
IA
|
1
|
Names of Reporting Persons.
DME Advisors LP
|
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
(a) [ ]
|
||
(b) [ ]
|
||
3
|
SEC Use Only
|
|
4
|
Citizenship or Place of Organization.
Delaware
|
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
0 shares
|
|
6 Shared Voting Power
191,900 shares
|
||
7 Sole Dispositive Power
0 shares
|
||
8 Shared Dispositive Power
191,900 shares
|
||
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
191,900 shares
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ]
|
|
11
|
Percent of Class Represented by Amount in Row (9)
0.8%
|
|
12
|
Type of Reporting Person (See Instructions)
IA
|
1
|
Names of Reporting Persons.
DME Advisors GP, LLC
|
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
(a) [ ]
|
||
(b) [ ]
|
||
3
|
SEC Use Only
|
|
4
|
Citizenship or Place of Organization.
Delaware
|
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
0 shares
|
|
6 Shared Voting Power
1,081,831 shares
|
||
7 Sole Dispositive Power
0 shares
|
||
8 Shared Dispositive Power
1,081,831 shares
|
||
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
1,081,831 shares
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ]
|
|
11
|
Percent of Class Represented by Amount in Row (9)
4.7%
|
|
12
|
Type of Reporting Person (See Instructions)
HC
|
1
|
Names of Reporting Persons.
David Einhorn
|
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
(a) [ ]
|
||
(b) [ ]
|
||
3
|
SEC Use Only
|
|
4
|
Citizenship or Place of Organization.
U.S. Citizen
|
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
0 shares
|
|
6 Shared Voting Power
2,027,027 shares
|
||
7 Sole Dispositive Power
0 shares
|
||
8 Shared Dispositive Power
2,027,027 shares
|
||
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
2,027,027 shares
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ]
|
|
11
|
Percent of Class Represented by Amount in Row (9)
8.7%
|
|
12
|
Type of Reporting Person (See Instructions)
HC
|
Item 4.
|
Ownership
|
Exhibits
|
Exhibit
|
99.1
|
Joint Filing Agreement by and among the Reporting Persons.
|
Date:
|
February 16, 2021
|
GREENLIGHT CAPITAL, INC.
|
|
By: /s/ DANIEL ROITMAN
|
|
Daniel Roitman
Chief Operating Officer
|
|
DME CAPITAL MANAGEMENT, LP
|
|
By: DME Advisors GP, LLC,
|
|
its General Partner
|
|
By: /s/ DANIEL ROITMAN
|
|
Daniel Roitman
Chief Operating Officer
|
|
DME ADVISORS, LP
|
|
By: DME Advisors GP, LLC, |
|
its General Partner | |
By: /s/ DANIEL ROITMAN
|
|
Daniel Roitman
Chief Operating Officer
|
|
DME ADVISORS GP, LLC
|
|
By: /s/ DANIEL ROITMAN
|
|
Daniel Roitman
Chief Operating Officer
|
|
/s/ DANIEL ROITMAN*
|
|
Daniel Roitman, on behalf of David Einhorn
|
GREENLIGHT CAPITAL, INC.
|
|
By: /s/ DANIEL ROITMAN
|
|
Daniel Roitman
Chief Operating Officer
|
|
DME CAPITAL MANAGEMENT, LP
|
|
By: DME Advisors GP, LLC,
|
|
its General Partner
|
|
By: /s/ DANIEL ROITMAN
|
|
Daniel Roitman
Chief Operating Officer
|
|
DME ADVISORS, LP
|
|
By: DME Advisors GP, LLC, |
|
its General Partner | |
By: /s/ DANIEL ROITMAN
|
|
Daniel Roitman
Chief Operating Officer
|
|
DME ADVISORS GP, LLC
|
|
By: /s/ DANIEL ROITMAN
|
|
Daniel Roitman
Chief Operating Officer
|
|
/s/ DANIEL ROITMAN*
|
|
Daniel Roitman, on behalf of David Einhorn
|